Legal Opinion
In re Nexium
District Court, D. Massachusetts
Decided September 11, 2013No. Civil Action No. 12-md-02409-WGYPublishedCited by 43 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
YOUNG, District Judge.
I. INTRODUCTION
A group of wholesale drug distributors (the “Direct Purchasers”) and health and welfare benefit funds (the “End-Payors” 1) (collectively, the “Plaintiffs”), on behalf of themselves and all others similarly situated, brings this multidistrict, putative class action against AstraZeneca AB, Aktiebolaget Hassle, and AstraZeneca LP (collectively, “AstraZeneca”), Ranbaxy Pharmaceuticals, Inc., Ranbaxy Inc., and Ranbaxy Laboratories Ltd. (collectively, “Ranbaxy”); Teva Pharmaceutical Industries, Ltd. and Teva Pharmaceuticals USA, Inc.…
2Cases cited91 opinions
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
- Warth v. SeldinSupreme Court of the United States · 1975
- Steel Co. v. Citizens for a Better EnvironmentSupreme Court of the United States · 1998
- Lewis v. CaseySupreme Court of the United States · 1996
86 more not listed; retrieve them via the Exa API.
3Cited by43 opinions
- AstraZeneca AB v. United Food & Commercial Workers UnionsCourt of Appeals for the First Circuit · 2015
- In Re Lipitor Antitrust LitigationCourt of Appeals for the Third Circuit · 2017
- In re Broiler Chicken Antitrust Litig.District Court, E.D. Illinois · 2017
- In re Niaspan Antitrust LitigationDistrict Court, E.D. Pennsylvania · 2014
- In re Aggrenox Antitrust LitigationDistrict Court, D. Connecticut · 2015
38 more not listed; retrieve them via the Exa API.